Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 1

5015 - The study of tumor associated exosomes in crosstalk between esophageal carcinoma and lymphatic endothelial cells


28 Sep 2019


Poster Display session 1


Tumour Site

Oesophageal Cancer


Weimin Mao


Annals of Oncology (2019) 30 (suppl_5): v747-v755. 10.1093/annonc/mdz266


W. Mao1, A. Zhao2

Author affiliations

  • 1 Thoracic Surgery, Cancer Hospital of University of Chinese Academy of Sciences, , 310022 - Hangzhou/CN
  • 2 Cancer Hospital Of University Of Chinese Academy Of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, 310022 - Hangzhou/CN


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 5015


Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in china. Because the disease often has no symptoms in the early stages, it is usually detected at a more advanced stage that is more challenging to treat. The inter-communication between esophageal squamous cell carcinoma and its surrounding microenvironment is essential for tumor progression and metastasis. Exosome plays a key role in information delivery between primary lesion and pre-metastatic niche via its packed bioactive molecules. The aim of this study is to explore the effect of exosome from tumor plasma to angiogenesis in human lymphatic endothelial cells (HLEC) in vitro.


Total circulation exosomes (CEs) were extracted and purified to selectively capture EpCAM positive exosomes by magnetic-bead technique. Proteins were separated by SDS-PAGE, and protein bands were analyzed by mass spectrometry. Tube formation assay and fluorescence imaging assay were performed in vitro.


The expression level of CEs in ESCC patients with lymph node metastasis were significantly higher than that in ESCC patients without metastasis and healthy control group (respectively; P < 0.001). The tumor associated exosomes could be taken by HLEC and its transferred into HLECs could to promote HLECs tube formation in vitro. In addition, the mass spectrometry was used to analysis the proteomic content in tumor associated exosomes, tumor-related proteins such as matrix-metalloproteinases, PP2A proteins and EIF proteins were identified in the exosome.


Exosomes released by ESCC may play important roles in the microenvironment of ESCC and provide a potential application of therapy.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Zhejiang Cancer Hospital.




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.